Advertisement

Research & Analysis

More than one in three patients abandoned their first buprenorphine prescription for opioid use disorder in 2024, up from 19% in 2020, according to a study published Aug. 4 in JAMA Network Open. Researchers found that 25.8% of first buprenorphine…

A state-commissioned evaluation of New York’s assisted outpatient treatment program found that voluntary outpatient mental health services produced many of the same positive outcomes as court-ordered treatment, while participants receiving voluntary care experienced fewer arrests and psychiatric hospitalizations, Politico reported…

Psilocybin-assisted therapy was safe and associated with large reductions in post-traumatic stress disorder symptoms among U.S. military veterans with severe, treatment-resistant PTSD, according to a study published July 30 in Communications Medicine. Researchers conducted an open-label pilot trial at The…

More than one-third (38%) of adolescents in the Adolescent Brain Cognitive Development (ABCD) Study reported lifetime substance use by age 16, with alcohol, cannabis and nicotine accounting for most use, according to a study published July 23 in Drug and…

Children’s Hospital of Philadelphia increased average monthly naloxone, known as Narcan, co-prescribing for patients receiving outpatient opioid prescriptions from 3% to 84.1% through an enterprisewide quality improvement initiative, according to a study published June 16 in The Journal of Pediatrics. The…

Advertisement

Vizient projects behavioral health outpatient volumes to grow 22% over the next decade, more than seven times the 3% increase predicted by population trends alone, according to the company’s 2026 Impact of Change forecast. Vizient’s forecast models 10-year demand projections…

Extreme opioid tolerance among illicit fentanyl users may be a major reason methadone induction has become more difficult in the fentanyl era, according to a study published June 9 in the Drug and Alcohol Dependence. Researchers from University of California…

Pediatric cannabis exposures jumped more than 6,000% among U.S. children younger than 6 between 2009 and 2024, according to a study published June 26 in the Journal of Addiction Medicine.  Researchers from the Medical College of Wisconsin in Milwaukee and…

Advertisement